India is targeting a $300 billion (₹25 lakh crore) bioeconomy by 2030 to become a global biotech leader. On July 7, Union Science & Technology Minister Dr. Jitendra Singh urged public participation, highlighting India’s biotech growth—from $10 billion in 2014 to $165.7 billion in 2024. Government support, startup boom, and innovation are driving this transformation.
BulletsIn
- India targets $300 bn bioeconomy by 2030 under biotech-led growth plan
- Sector grew from $10 bn in 2014 to $165.7 bn in 2024
- Biotech now contributes 4.25% to India’s GDP
- Startups rose from 50 (2014) to nearly 11,000 in 2024
- BIRAC launched 95 bio-incubators; backed 100s of startups
- Schemes like BIG, SEED, LEAP aiding healthcare, AI, diagnostics
- National Biopharma Mission backed 101 projects, boosted vaccine output
- Ethanol blending rose to 15% in 2024; oil import bill cut
- Biotech-KISAN helped 37,000+ women farmers in West Bengal
- New policy BioE3 to boost rural jobs, green tech, carbon cuts




What do you think?
It is nice to know your opinion. Leave a comment.